<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hamilton MP</submitter><funding>NIDDK NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>2730</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3868236</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4</volume><pubmed_abstract>MicroRNAs modulate tumorigenesis through suppression of specific genes. As many tumour types rely on overlapping oncogenic pathways, a core set of microRNAs may exist, which consistently drives or suppresses tumorigenesis in many cancer types. Here we integrate The Cancer Genome Atlas (TCGA) pan-cancer data set with a microRNA target atlas composed of publicly available Argonaute Crosslinking Immunoprecipitation (AGO-CLIP) data to identify pan-tumour microRNA drivers of cancer. Through this analysis, we show a pan-cancer, coregulated oncogenic microRNA 'superfamily' consisting of the miR-17, miR-19, miR-130, miR-93, miR-18, miR-455 and miR-210 seed families, which cotargets critical tumour suppressors via a central GUGC core motif. We subsequently define mutations in microRNA target sites using the AGO-CLIP microRNA target atlas and TCGA exome-sequencing data. These combined analyses identify pan-cancer oncogenic cotargeting of the phosphoinositide 3-kinase, TGF? and p53 pathways by the miR-17-19-130 superfamily members.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.</pubmed_title><pmcid>PMC3868236</pmcid><funding_grant_id>P30CA125123</funding_grant_id><funding_grant_id>P30 DK079638</funding_grant_id><funding_grant_id>1K01DK096093</funding_grant_id><funding_grant_id>K01 DK096093</funding_grant_id><funding_grant_id>U54 HG003079</funding_grant_id><funding_grant_id>P30-DK079638</funding_grant_id><funding_grant_id>P30 CA125123</funding_grant_id><pubmed_authors>Hamilton MP</pubmed_authors><pubmed_authors>Hartig SM</pubmed_authors><pubmed_authors>Reva B</pubmed_authors><pubmed_authors>Gunaratne PH</pubmed_authors><pubmed_authors>Coarfa C</pubmed_authors><pubmed_authors>Rajapakshe K</pubmed_authors><pubmed_authors>McLellan MD</pubmed_authors><pubmed_authors>McGuire SE</pubmed_authors><pubmed_authors>Wheeler DA</pubmed_authors><pubmed_authors>Kandoth C</pubmed_authors><pubmed_authors>Zack TI</pubmed_authors><pubmed_authors>Ding L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.</name><description>MicroRNAs modulate tumorigenesis through suppression of specific genes. As many tumour types rely on overlapping oncogenic pathways, a core set of microRNAs may exist, which consistently drives or suppresses tumorigenesis in many cancer types. Here we integrate The Cancer Genome Atlas (TCGA) pan-cancer data set with a microRNA target atlas composed of publicly available Argonaute Crosslinking Immunoprecipitation (AGO-CLIP) data to identify pan-tumour microRNA drivers of cancer. Through this analysis, we show a pan-cancer, coregulated oncogenic microRNA 'superfamily' consisting of the miR-17, miR-19, miR-130, miR-93, miR-18, miR-455 and miR-210 seed families, which cotargets critical tumour suppressors via a central GUGC core motif. We subsequently define mutations in microRNA target sites using the AGO-CLIP microRNA target atlas and TCGA exome-sequencing data. These combined analyses identify pan-cancer oncogenic cotargeting of the phosphoinositide 3-kinase, TGF? and p53 pathways by the miR-17-19-130 superfamily members.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2020-11-19T15:16:57Z</modification><creation>2019-03-27T01:18:44Z</creation></dates><accession>S-EPMC3868236</accession><cross_references><pubmed>24220575</pubmed><doi>10.1038/ncomms3730</doi></cross_references></HashMap>